Published 2 years ago • loading... • Updated 2 years ago

Immunotherapy-Resistant Cancer Patients Lack Critical Immune Cells

Summary by GEN - Genetic Engineering and Biotechnology News…

The amount of CD5+ dendritic cells inside tumors could be used to help doctors assess which patients are most likely to benefit from immunotherapy.

1 Articles

All

Left

Center

Right

The amount of CD5+ dendritic cells inside tumors could be used to help doctors assess which patients are most likely to benefit from immunotherapy.

2 years ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated2 years agoBias Distribution

No sources with tracked biases.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

GEN - Genetic Engineering and Biotechnology News… broke the news in 2 years ago on Tuesday, February 21, 2023.

Sources are mostly out of (0)